ClinicalTrials.gg
Sign In
CompletedNCT01850433Updated Aug 18, 2017

Internet Cognitive Behavior Therapy (CBT) for Body Dysmorphic Disorder (BDD)

An interventional study of Internet based CBT for body dysmorphic disorder in Body Dysmorhpic Disorder, sponsored by Karolinska Institutet. Completed at 1 site in Sweden. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-08-18.

Sponsored by Karolinska Institutet · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
23
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The primary aim is to develop, and test the feasibility, of a novel and protocol-based cognitive behaviour therapy (CBT) treatment for body dysmorphic disorder (BDD) administered via the Internet.

02

Conditions studied

  • Body Dysmorhpic Disorder

Keywords

  • BDD
  • CBT
03

In context

Lead sponsor

Karolinska Institutet is the lead sponsor of 1,146 studies on the registry; 275 are open to participants now.

Browse Karolinska Institutet studies →

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • outpatients

  • male or female

    -≥ 18 years

  • currently living in Stockholm county
  • primary diagnosis of BDD according to the DSM-IV-TR
  • signed informed consent
  • regular access to a computer with Internet access and skills to use the web.

Exclusion criteria

Exclusion Criteria:

  • psychotropic medication changes within two months prior to the treatment
  • completed CBT for BDD within the last 12 months
  • BDD-YBOCS \< 12 at psychiatrist visit
  • other primary axis I diagnosis
  • current substance dependence
  • lifetime bipolar disorder or psychosis
  • suicidal ideation
  • Axis II diagnosis that could jeopardize treatment participation
  • other current psychological treatment that could affect BDD symptoms
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
23 participants (actual)

Study arms

  • Experimental
    Internet CBT

    Behavioral: Internet based CBT for body dysmorphic disorder

Interventions

  • BehavioralInternet based CBT for body dysmorphic disorder
06

What researchers measure

Primary outcomes

  1. Body dysmorphic disorder symptoms

    Time frame: Measured after 12 weeks of treatment, and after 3 months after treatment

Secondary outcomes

  1. Functioning and life satisfaction

    Time frame: After 12 weeks of treatment, and 3 months after treatment

  2. Depressive symptoms

    Time frame: After 12 weeks of treatment, and 3 months after treatment

07

Study locations

1 site
  • M46 Huddinge sjukhus, Internetpsykiatrienheten/mottagningen för tvångssyndrom
    Stockholm, 141 86, Sweden
08

References and documents

Publications

  • Enander J, Ivanov VZ, Andersson E, Mataix-Cols D, Ljotsson B, Ruck C. Therapist-guided, Internet-based cognitive-behavioural therapy for body dysmorphic disorder (BDD-NET): a feasibility study. BMJ Open. 2014 Sep 25;4(9):e005923. doi: 10.1136/bmjopen-2014-005923. PubMed 25256187 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Mar 2013 to primary completion in Mar 2014, 12 months.

How these figures are worked out, and which studies are left out of them.

Registered
May 7, 2013
First posted
May 9, 2013
StartActual
Mar 2013
Primary completionActual
Mar 2014
CompletionActual
Mar 2014
Last update
Aug 18, 2017
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 18, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01850433
Lead sponsor
Karolinska Institutet
Responsible party
Christian Rück (Associate professor, M.D., Karolinska Institutet) — Principal investigator
First posted
May 9, 2013
Start date
Mar 2013
Primary completion
Mar 2014
Completion
Mar 2014
Last update
Aug 18, 2017

Study contacts

Christian Rück, MD, PhD
principal investigator · Karolinska Institutet

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Karolinska Institutet →

Start the discussion